Blayney DW - Search Results

1

Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia in Adults With Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.

Blayney DW, Zhang Q, Feng J, Zhao Y, Bondarenko I, Vynnychenko I, Kovalenko N, Nair S, Ibrahim E, Udovista DP, Mohanlal R, Ogenstad S, Ette E, Du L, Huang L, Shi YK. Blayney DW, et al. JAMA Oncol. 2020 Nov 1;6(11):e204429. doi: 10.1001/jamaoncol.2020.4429. Epub 2020 Nov 12. JAMA Oncol. 2020. PMID: 32970104 Free PMC article. Clinical Trial.

2

Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.

Kesler SR, Blayney DW. Kesler SR, et al. Among authors: blayney dw. JAMA Oncol. 2016 Feb;2(2):185-92. doi: 10.1001/jamaoncol.2015.4333. JAMA Oncol. 2016. PMID: 26633037 Free PMC article.

3

Efficacy of Medicaid for Patients With Cancer in California.

Blayney DW. Blayney DW. JAMA Oncol. 2018 Mar 1;4(3):323-325. doi: 10.1001/jamaoncol.2017.4356. JAMA Oncol. 2018. PMID: 29192302 No abstract available.

4

Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Docetaxel-Induced Neutropenia in Patients With Solid Tumors: A Randomized Clinical Trial.

Blayney DW, Mohanlal R, Adamchuk H, Kirtbaya DV, Chen M, Du L, Ogenstad S, Ginn G, Huang L, Zhang Q. Blayney DW, et al. JAMA Netw Open. 2022 Jan 4;5(1):e2145446. doi: 10.1001/jamanetworkopen.2021.45446. JAMA Netw Open. 2022. PMID: 35084480 Free PMC article. Clinical Trial.

5

Grade 4 Neutropenia Frequency as a Binary Risk Predictor for Adverse Clinical Consequences of Chemotherapy‑Induced Neutropenia: A Meta-analysis.

Mohanlal R, Ogenstad S, Lyman GH, Huang L, Blayney DW. Mohanlal R, et al. Among authors: blayney dw. Cancer Invest. 2023 Apr;41(4):369-378. doi: 10.1080/07357907.2023.2179064. Epub 2023 Mar 8. Cancer Invest. 2023. PMID: 36856462 Free article.

6

Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.

Blayney DW, McGuire BW, Cruickshank SE, Johnson DH. Blayney DW, et al. Oncologist. 2005 Feb;10(2):138-49. doi: 10.1634/theoncologist.10-2-138. Oncologist. 2005. PMID: 15709216 Free article. Clinical Trial.

7

Critical Lessons From High-Value Oncology Practices.

Blayney DW, Simon MK, Podtschaske B, Ramsey S, Shyu M, Lindquist C, Milstein A. Blayney DW, et al. JAMA Oncol. 2018 Feb 1;4(2):164-171. doi: 10.1001/jamaoncol.2017.3803. JAMA Oncol. 2018. PMID: 29145584 Free PMC article.

8

Pioneering Cancer Quality: Lessons From Dr Joe Simone.

Blayney DW. Blayney DW. JCO Oncol Pract. 2021 Aug;17(8):505-506. doi: 10.1200/OP.21.00358. Epub 2021 Jul 15. JCO Oncol Pract. 2021. PMID: 34264751 No abstract available.

9

Cancer Biosimilars-A Regulatory Success So Far, but Value Still to Be Determined.

Blayney DW, Silver SM. Blayney DW, et al. JAMA Oncol. 2022 Apr 1;8(4):520-521. doi: 10.1001/jamaoncol.2021.6979. JAMA Oncol. 2022. PMID: 35113156 No abstract available.

10

Chemotherapy-induced neutropenia and emerging agents for prevention and treatment: A review.

Blayney DW, Schwartzberg L. Blayney DW, et al. Cancer Treat Rev. 2022 Sep;109:102427. doi: 10.1016/j.ctrv.2022.102427. Epub 2022 Jun 21. Cancer Treat Rev. 2022. PMID: 35785754 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters